Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells

European Journal of Cancer

Volumn 36, Issue 6, 2000, Pages 796-802

  Salti, G I ^a   Grewal, S ^a   Mehta, R R ^a   Das Gupta, T K ^a   Boddie, A W ^a   Constantinou, A I ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Apoptosis; Colon cancer; Comet assay; DNA breakage; Genistein

Indexed keywords

ACLARUBICIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GENISTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CULTURE; CELL CYCLE; COLON CANCER; COMET ASSAY; CONTROLLED STUDY; DNA CLEAVAGE; DNA DAMAGE; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACLARUBICIN; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENISTEIN; GROWTH INHIBITORS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0034033956     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00017-4     Document Type: Article

References (30)

1. Uckun F.M., Evans W.E., Forsyth C.J.et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science. 267:1995;886-891.
2. Uckun F.M., Narla R.K., Jun X.et al. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. Clin. Cancer Res. 4:1998;901-912.
3. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr. 125(Suppl.):1995;784S-789S.
4. Fotsis T., Pepper M., Adlercreutz H.et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA. 90:1993;2690-2694.
5. Murrill W.B., Brown N.M., Zhang J.X.et al. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 17:1996;1451-1457.
6. Zava D.T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer. 27:1997;31-40.
7. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58:1998;3833-3838.
8. Rao C.V., Wang C.X., Simi B.et al. Enhancement of experimental colon cancer by genistein. Cancer Res. 57:1997;3717-3722.
9. Constantinou A.I., Kiguchi K., Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50:1990;2618-2624.
10. Constantinou A., Huberman E. Genistein as an inducer of tumor cell differentiation. possible mechanisms of action Proc. Soc. Exp. Biol. Med. 208:1995;109-115.
11. Shao Z.M., Wu J., Shen Z.Z., Barsky Sh. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58:1998;4851-4857.
12. Barnes S., Peterson T.G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med. 208:1995;103-108.
13. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
14. Duthie S.J., Ma A., Ross M.A., Collins A.R. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 56:1996;1291-1295.
15. Collins A.R., Ai-guo M., Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mut. Res. 336:1995;69-77.
16. Duke R.C., Cohen J.J. Morphological and biochemical assays of apoptosis. Coligan J.E., Kruisbeak A.M. Current Protocols in Immunology. 1992;3.17.1 John Wiley & Sons, New York.
17. Videløv L.L., Christensen I.J., Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327.
18. Bertrand R., Sarang M., Jenkin J., Kerrigan D., Pommier Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitiors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51:1991;6280-6285.
19. Long B.H., Musial S.T., Brattain M.G. Single-and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res. 45:1985;3106-3112.
20. Bertrand R., Kerrigan D., Sarang M., Pommier Y. Cell death induced by topoisomerase inhibitors. role of calcium in mammalian cells Biochem. Pharmacol. 42:1991;77-85.
21. Constantinou A., Mehta R., Runyan C., Rao K., Vaughan A., Moor R. Flavonoids as DNA topoisomerase antagonists and poisons, structure-activity relationships. J. Nat. Prod. 58:1995;217-225.
22. Markovitz J., Linassier C., Fosse P.et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:1989;5111-5117.
23. Jensen P.B., Sørensen B.S., Demant E.J.et al. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Cancer Res. 50:1990;3311-3316.
24. Harker W.G., Slade D.L., Parr R.L., Feldhoff P.W., Sullivan D.M., Holguin M.H. Alteration in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukaemia cell line. Cancer Res. 55:1995;1707-1716.
25. Kusumoto H., Rodgers Q.E., Boege F., Raimondi S.C., Beck W.T. Characterization of novel human leukemia cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II. Cancer Res. 56:1996;2573-2583.
26. Markovits J., Junqua S., Goldwasser F.et al. Genistein resistance in human leukaemic CCRF-CEM cells. selection of a diploid cell line with reduced topoisomerase IIβ isoform Biochem. Pharmcol. 50:1995;177-186.
27. Perrin D., van Hille B., Hill B.T. Differential sensitivities of recombinant human topoisomerase IIα and β to various classes of topoisomerase II-interacting agents. Biochem. Pharmcol. 56:1998;503-507.
28. Ritke M.K., Rusnak J.M., Lazo J.S.et al. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol. Pharmacol. 46:1994;605-611.
29. Beere H.M., Chresta C., Hickman J.A. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells. Mol. Pharmacol. 49:1996;842-851.
30. Hendrickse C.W., Jones C.E., Donovan I.A., Neoptolemos J.P., Baker P.R. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br. J. Surg. 80:1993;636-640.